0.00Open0.60Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover1376.32%IV6.50%PremiumJul 19, 2024Expiry Date0.12Intrinsic Value100Multiplier-4DDays to Expiry0.48Extrinsic Value100Contract SizeAmericanOptions Type-0.6036Delta0.3857Gamma12.30Leverage Ratio-5.2508Theta0.0000Rho-7.42Eff Leverage0.0003Vega
MiMedx Stock Discussion
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx(MDXG.US)$